Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 325

1.

Inhibition of Cdk5 induces cell death of tumor-initiating cells.

Mandl MM, Zhang S, Ulrich M, Schmoeckel E, Mayr D, Vollmar AM, Liebl J.

Br J Cancer. 2017 Mar 28;116(7):912-922. doi: 10.1038/bjc.2017.39. Epub 2017 Feb 21.

PMID:
28222068
2.

Biological functions of CDK5 and potential CDK5 targeted clinical treatments.

Shupp A, Casimiro MC, Pestell RG.

Oncotarget. 2017 Mar 7;8(10):17373-17382. doi: 10.18632/oncotarget.14538. Review.

3.

Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China.

Pan DH, Zhu ML, Lin XM, Lin XG, He RQ, Ling YX, Su ST, Wickramaarachchi MM, Dang YW, Wei KL, Chen G.

Eur J Med Res. 2016 Jul 12;21(1):28. doi: 10.1186/s40001-016-0222-0.

4.

The O-GlcNAc Modification of CDK5 Involved in Neuronal Apoptosis Following In Vitro Intracerebral Hemorrhage.

Ning X, Tao T, Shen J, Ji Y, Xie L, Wang H, Liu N, Xu X, Sun C, Zhang D, Shen A, Ke K.

Cell Mol Neurobiol. 2017 Apr;37(3):527-536. doi: 10.1007/s10571-016-0391-y. Epub 2016 Jun 17.

PMID:
27316643
5.

An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.

Wei K, Ye Z, Li Z, Dang Y, Chen X, Huang N, Bao C, Gan T, Yang L, Chen G.

World J Surg Oncol. 2016 Feb 9;14(1):34. doi: 10.1186/s12957-016-0787-7.

6.

Cdk5 Regulates Activity-Dependent Gene Expression and Dendrite Development.

Liang Z, Ye T, Zhou X, Lai KO, Fu AK, Ip NY.

J Neurosci. 2015 Nov 11;35(45):15127-34. doi: 10.1523/JNEUROSCI.1443-15.2015. Erratum in: J Neurosci. 2016 Jan 6;36(1):262.

7.

Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5.

Takada S, Mizuno K, Saito T, Asada A, Giese KP, Hisanaga S.

PLoS One. 2015 Oct 15;10(10):e0140821. doi: 10.1371/journal.pone.0140821. eCollection 2015.

8.

Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients.

Zhang X, Zhong T, Dang Y, Li Z, Li P, Chen G.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8066-74. eCollection 2015.

9.

Insights into the clinical value of cyclin-dependent kinase 5 in glioma: a retrospective study.

Yushan R, Wenjie C, Suning H, Yiwu D, Tengfei Z, Madushi WM, Feifei L, Changwen Z, Xin W, Roodrajeetsing G, Zuyun L, Gang C.

World J Surg Oncol. 2015 Jul 25;13:223. doi: 10.1186/s12957-015-0629-z.

10.

Cyclin-dependent kinase 5 regulates the proliferation, motility and invasiveness of lung cancer cells through its effects on cytoskeletal remodeling.

Liu JL, Gu RX, Zhou XS, Zhou FZ, Wu G.

Mol Med Rep. 2015 Sep;12(3):3979-85. doi: 10.3892/mmr.2015.3868. Epub 2015 May 27.

PMID:
26018459
11.

Targeting cyclin dependent kinase 5 in hepatocellular carcinoma--A novel therapeutic approach.

Ehrlich SM, Liebl J, Ardelt MA, Lehr T, De Toni EN, Mayr D, Brandl L, Kirchner T, Zahler S, Gerbes AL, Vollmar AM.

J Hepatol. 2015 Jul;63(1):102-13. doi: 10.1016/j.jhep.2015.01.031. Epub 2015 Feb 7.

PMID:
25660209
12.

Cyclin-dependent kinase 5 decreases in gastric cancer and its nuclear accumulation suppresses gastric tumorigenesis.

Cao L, Zhou J, Zhang J, Wu S, Yang X, Zhao X, Li H, Luo M, Yu Q, Lin G, Lin H, Xie J, Li P, Hu X, Zheng C, Bu G, Zhang YW, Xu H, Yang Y, Huang C, Zhang J.

Clin Cancer Res. 2015 Mar 15;21(6):1419-28. doi: 10.1158/1078-0432.CCR-14-1950. Epub 2015 Jan 21.

13.

Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with a loss-of-function mutation in CDK5.

Magen D, Ofir A, Berger L, Goldsher D, Eran A, Katib N, Nijem Y, Vlodavsky E, Tzur S, Behar DM, Fellig Y, Mandel H.

Hum Genet. 2015 Mar;134(3):305-14. doi: 10.1007/s00439-014-1522-5. Epub 2015 Jan 6. Erratum in: Hum Genet. 2015 Mar;134(3):315. Katib, Nassser [corrected to Katib, Nasser]; Zur, Shay [corrected to Tzur, Shay].

PMID:
25560765
14.

Cyclin-dependent kinase 5 regulates degranulation in human eosinophils.

Odemuyiwa SO, Ilarraza R, Davoine F, Logan MR, Shayeganpour A, Wu Y, Majaesic C, Adamko DJ, Moqbel R, Lacy P.

Immunology. 2015 Apr;144(4):641-8. doi: 10.1111/imm.12416.

15.

All-trans retinoic acid induces DU145 cell cycle arrest through Cdk5 activation.

Lin E, Chen MC, Huang CY, Hsu SL, Huang WJ, Lin MS, Wu JC, Lin H.

Cell Physiol Biochem. 2014;33(6):1620-30. doi: 10.1159/000358724. Epub 2014 May 16.

16.

CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression.

Liang Q, Li L, Zhang J, Lei Y, Wang L, Liu DX, Feng J, Hou P, Yao R, Zhang Y, Huang B, Lu J.

Sci Rep. 2013 Oct 14;3:2932. doi: 10.1038/srep02932.

17.

Cyclin-dependent kinase 5 promotes the stability of corneal epithelial cell junctions.

Arpitha P, Gao CY, Tripathi BK, Saravanamuthu S, Zelenka P.

Mol Vis. 2013;19:319-32. Epub 2013 Feb 7.

18.

Association between plasma biomarkers, CDK5 polymorphism and the risk of Alzheimer's disease.

Czapski GA, Maruszak A, Styczyńska M, Żekanowski C, Safranow K, Strosznajder JB.

Acta Neurobiol Exp (Wars). 2012;72(4):397-411.

19.

Cyclin-dependent kinase 5 in axon growth and regeneration.

Ye T, Fu AK, Ip NY.

Int Rev Neurobiol. 2012;105:91-115. doi: 10.1016/B978-0-12-398309-1.00006-8. Review.

PMID:
23206597
20.

Synaptic vesicle pools and dynamics.

Alabi AA, Tsien RW.

Cold Spring Harb Perspect Biol. 2012 Aug 1;4(8):a013680. doi: 10.1101/cshperspect.a013680. Review.

Supplemental Content

Support Center